Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > Weekly NIH Funding Opportunities, Notices: May 19, 2017

Weekly NIH Funding Opportunities, Notices: May 19, 2017



Notices
Requests for Applications

     

  • Specialized Alcohol Research Centers (P50) 
    (RFA-AA-18-001)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): December 5, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • Silencing of HIV-1 Proviruses (R61/R33)
    (RFA-AI-17-013)
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute of Mental Health
    Application Receipt Date(s): December 6, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
    (RFA-AT-18-001)
    National Center for Complementary and Integrative Health
    Application Receipt Date(s): August 4, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)
    (RFA-DK-17-006)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • Psychological, Behavioral, and Neurocognitive-Focused Ancillary Studies to the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) (U01)
    (RFA-DK-17-009)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): October 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • SBIR E-learning for HAZMAT and Emergency Response (R43/R44) 
    (RFA-ES-17-004)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 28, 2017), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34) 
    (RFA-HL-18-008)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01)
    (RFA-HL-18-009)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Basic Research in Calcific Aortic Valve Disease (R01) 
    (RFA-HL-18-010)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01)
    (RFA-MH-18-400)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Program Announcements

     

  • Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)
    (PA-17-288)
    National Cancer Institute
    Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)
    (PA-17-289)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01)
    (PA-17-291)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)
    (PA-17-292)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NIA Academic Leadership Career Award (K07)
    (PAR-17-287)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25)
    (PAR-17-290)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)
    (PAR-17-293)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. ***This FOA is being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. This FOA will be reissued for additional due date(s) on or after January 25, 2018.***. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.